Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract


Genaissance Pharmaceuticals, Inc. announced that it will provide its high-throughput Genotyping services to Biotronics Ltd., headquartered in Nicosia, Cyprus, which has been awarded a contract by the Veterinary services in the Ministry of agriculture, Natural Resources & Environment as part of Cyprus' efforts to implement the European Union's (EU) mandate for establishing a breeding program in sheep that confers resistance to scrapie. Under the terms of the contract, Biotronics will collect the tissue specimens from the Veterinary Services and send them to Genaissance's genotyping facility in New Haven, CT, where Genaissance will analyze a minimum of 100,000 samples over approximately a three-month period of time.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy